What You Should Know:
- Guardant Health, a provider in precision oncology, and ConcertAI, a real-world evidence (RWE) and AI technology company in oncology, announced a strategic collaboration that will provide biopharmaceutical companies with access to a first-of-its-kind multi-modal real-world data (RWD) solution.
- The partnership integrates comprehensive patient electronic medical record (EMR) data with genomic and epigenomic tumor profiling information, offering a deeper
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
ScreenPoint Medical Acquires Biomediq to Enhance Breast Cancer Risk Assessment with AI
What You Should Know:
- ScreenPoint Medical, a provider of AI-powered breast cancer screening solutions, acquires Biomediq A/S, a research-based company specializing in quantitative imaging biomarkers. Financial details of the acquisition were not disclosed.
- ScreenPoint's industry-leading Transpara AI platform will now incorporate Biomediq's advanced risk analysis technology, which enables automated analysis of 2D and 3D mammograms to assess future breast cancer risk. This
Read More
Certis Oncology Launches AI-Powered Chatbot for Cancer Research
What You Should Know:
- Certis Oncology Solutions, a translational science and emerging technology leader in preclinical oncology research, is pleased to announce the commercial launch of CertisOI Assistant™, an innovative chatbot tool designed to enhance the efficiency and effectiveness of cancer research.
- This cutting-edge research tool leverages artificial intelligence/machine learning (AI/ML) and OpenAI’s ChatGPT language model to provide researchers unparalleled insights
Read More
Function Health and GRAIL Collaborate to Make Multi-Cancer Early Detection Test More Accessible
What You Should Know:
- Function Health, a revolutionary health management platform empowering people to live 100 healthy years, announces a collaboration with GRAIL, Inc., a healthcare company whose mission is to detect cancer early when it can be cured, to expand the reach of innovative cancer screening to transform cancer care.
- Function Health’s 400,000+ members nationwide have access to GRAIL’s Galleri test—a first-of-its-kind, clinically validated multi-cancer early detection
Read More
Owkin, Proscia Partner to Streamline MSI Testing for Colorectal Cancer
What You Should Know:
- Owkin, an AI-biotech company specializing in precision medicine, and Proscia, a leader in AI-enabled pathology solutions, have announced a strategic partnership to improve MSI testing for colorectal cancer (CRC). This collaboration aims to enhance the efficiency and accessibility of MSI screening, ultimately leading to better patient outcomes.
- Beyond MSI testing, Owkin and Proscia plan to collaborate on developing and commercializing additional AI solutions
Read More
Ontada, Datavant Partner to Accelerate Oncology Innovation with Real-World Data
What You Should Know:
- Ontada, a McKesson business specializing in real-world data and clinical technology for community oncology, has announced a strategic collaboration with Datavant, a health data platform.
- The partnership aims to accelerate oncology innovation by providing life science companies with faster access to Ontada's comprehensive real-world data.
In October, Ontada partnered with Microsoft to utilize AI capabilities to extract actionable insights from vast
Read More
AI Against Cancer: Capabilities and Limitations for Early Detection and Treatment Planning
The American Cancer Society predicted 2 million new cancer cases in the US alone in 2024, which amounts to roughly 5,480 diagnoses every day. What makes matters worse is that the pandemic delayed care for more than 75% of cancer patients. Unsurprisingly, healthcare providers are turning to new technologies like AI in search of solutions. To gauge the magnitude of this trend, consider this: as of August 7, 2024, 950 AI/ML-enabled medical devices have received clearance from the FDA, with 76% of
Read More
Starget Pharma Secures $5.1M for AI-Powered Targeted Radiotherapy for Cancer
What You Should Know:
- Starget Pharma, an innovative startup specializing in precision cancer diagnostics and targeted radiotherapy, has secured $5.1M in funding from Cancer Focus, a fund established in collaboration with the renowned MD Anderson Cancer Center.
- The investment will support Starget Pharma's upcoming clinical trial for treating advanced metastatic cancers, including sarcomas, neuroendocrine tumors, melanoma, and liver cancer.
Revolutionizing Cancer Treatment
Read More
Ontada Transforms Unstructured Oncology Data with Microsoft Azure AI
What You Should Know:
- Ontada, a McKesson business specializing in oncology real-world data and evidence, has formed a strategic partnership with Microsoft to leverage the power of Azure AI in transforming cancer care.
- The partnership will harness the capabilities of Azure OpenAI Service to efficiently process vast amounts of unstructured oncology data, unlocking valuable insights and ultimately improving patient outcomes.
The Challenge of Unstructured Data in
Read More
miRoncol Develops Multi-Cancer Early Detection Blood Test
What You Should Know:
- miRoncol, a medtech startup, has announced the completion of proof-of-concept studies for a groundbreaking multi-cancer early detection blood test.
- The test utilizes microRNA analysis and machine learning, two technologies recognized by the 2024 Nobel Prizes, to identify cancers at their earliest stages, even before the onset of noticeable symptoms.
The Power of microRNA and Machine Learning
MicroRNAs (miRNAs) are small RNA molecules that play a
Read More
